Belvedere Trading
COLL icon

Belvedere Trading’s Collegium Pharmaceutical COLL Stock Holding History

Belvedere Trading’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,042
Closed -$145K – 894
2023
Q1 		$145K Buy
+6,042
New +$160K ﹤0.01% 394

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Belvedere Trading's COLL Position: Q2 2023 in Review

Belvedere Trading sold out of Collegium Pharmaceutical (COLL) in Q2 2023, closing a stake of 6,042 shares — an estimated $145K sold.

Belvedere Trading first reported a position in COLL in Q1 2023 and held it in 1 quarter. The position peaked at $145K in Q1 2023. 178 funds tracked by Wall St. Rank hold COLL as of Q2 2023.

  • Belvedere Trading reported no remaining Collegium Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • Belvedere Trading sold 6,042 Collegium Pharmaceutical shares in Q2 2023, an estimated $145K.
  • Belvedere Trading first reported a position in Collegium Pharmaceutical in Q1 2023 and held it in 1 quarter.
  • Belvedere Trading's Collegium Pharmaceutical position peaked at $145K in Q1 2023.
  • 178 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2023.

Based on Belvedere Trading's 13F filing for Q2 2023, filed 8 Aug 2023.